Point mutation, allelic loss and increased methylation of c-Ha-Ras gene in human hepatocellular carcinoma
Corresponding Author
Norio Ogata M. D.
Third Department of Internal Medicine, Niigata University School of Medicine, 1 Asahi-machi, Niigata, 951, Japan
National Institute of Allergy and Infectious Diseases, Building F, Room 201, National Institutes of Health, Bethesda, MD 20892===Search for more papers by this authorTomoteru Kamimura
Third Department of Internal Medicine, Niigata University School of Medicine, 1 Asahi-machi, Niigata, 951, Japan
Search for more papers by this authorHitoshi Asakura
Third Department of Internal Medicine, Niigata University School of Medicine, 1 Asahi-machi, Niigata, 951, Japan
Search for more papers by this authorCorresponding Author
Norio Ogata M. D.
Third Department of Internal Medicine, Niigata University School of Medicine, 1 Asahi-machi, Niigata, 951, Japan
National Institute of Allergy and Infectious Diseases, Building F, Room 201, National Institutes of Health, Bethesda, MD 20892===Search for more papers by this authorTomoteru Kamimura
Third Department of Internal Medicine, Niigata University School of Medicine, 1 Asahi-machi, Niigata, 951, Japan
Search for more papers by this authorHitoshi Asakura
Third Department of Internal Medicine, Niigata University School of Medicine, 1 Asahi-machi, Niigata, 951, Japan
Search for more papers by this authorAbstract
Somatic alterations of the c-Ha-ras gene were examined in 21 Japanese patients with hepatocellular carcinoma. Restriction endonuclease analysis by double digestion with MspI and HpaII revealed that DNAs from two of 21 hepatocellular carcinoma tissues were affected by nucleotide substitution at the twelfth amino acid coding sequence of the c-Ha-ras gene. DNAs from cirrhotic noncancerous liver tissue, but not leukocytes, of one of these patients possessed the mutation, whereas DNAs from noncirrhotic liver tissue and leukocytes of the other patient did not. In one of the nine patients harboring heterozygosity for c-Ha-ras—related BamHI-fragments, the loss of one allele was demonstrated as a somatic change not only in DNA from the tumor tissue but also in DNA from the cirrhotic nontumorous tissue. In two of the 19 patients comparatively examined for digestion patterns of c-Ha-ras locus with HpaII and MspI, extensive methylation was observed as a somatic modification in both DNAs from the tumor and the cirrhotic nontumorous tissues. These results thus indicate that the genetic lesions affecting the c-Ha-ras gene do occur in human hepatocellular carcinoma and probably serve as one of the multiple steps in the process of hepatic carcinogenesis. (HEPATOLOGY 1991; 13:31–37).
References
- 1 Beasley RP, Hwang L-Y. Epidemiology of hepatocellular carcinoma. In: GN Vyas, JL Dienstag, JH Hoofnagle, eds. Viral hepatitis and liver disease. Orlando, Fla: Grune & Stratton, Inc., 1984: 209–224.
- 2 Bréchot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen–positive and–negative liver disease. Proc Natl Acad Sci USA 1980; 78: 3906–3910.
- 3 Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 1981; 305: 1067–1073.
- 4 Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495.
- 5 Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. HEPATOLOGY 1987; 7: 764–772.
- 6 Gu J-R. Molecular aspects of human hepatic carcinogenesis. Carcinogenesis 1988; 9: 697–703.
- 7 Klein G, Klein E. Evolution of tumours and the impact of molecular oncology. Nature 1985; 315: 190–195.
- 8 Shih C, Shilo B, Goldfarb MP, Dannenberg A, Weinberg RA. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA 1979; 76: 5714–5718.
- 9 Bishop JM. The molecular genetics of cancer. Science 1987; 235: 305–311.
- 10 Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, et al. Mechanism of activation of human oncogene. Nature 1982; 300: 143–149.
- 11 Reddy EP, Reynolds RK, Santos E, Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 1982; 300: 149–152.
- 12 Taparowsky E, Suard Y, Fasano O, Shimizu K, Goldfarb M, Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 1982; 300: 762–765.
- 13 Yuasa Y, Srivastava SK, Dunn CY, Rhim JS, Reddy EP, Aaronson SA. Acquisition of transforming properties by alternative point mutations within c-bas/has human protooncogenes. Nature 1983; 313: 775–779.
- 14 Bos JL, Verlaan-DeVries M, Jansen AM, Veenman GH, van Boom JH, van der Eb AJ. Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res 1984; 12: 9155–9163.
- 15 Bos JL, Toksoz D, Marshall CJ, Verlaam-De Vries M, Veeneman GH, van der Eb AJ, van Boom JH, et al. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukemia. Nature 1985; 315: 726–730.
- 16 Fassano O, Aldrich T, Tamanoi F, Taparowsky E, Furth M, Wigler M. Analysis of the transforming potential of the human H-ras gene by random mutagenesis. Proc Natl Acad Sci USA 1984; 81: 4008–4012.
- 17 Chang EH, Furth ME, Scolnick EM, Lowy DR. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 1982; 297: 479–483.
- 18 Pulciani S, Santos E, Long LK, Sorrentino V, Barbacid M. Ras gene amplification and malignant transformation. Mol Cell Biol 1985; 5: 2836–2841.
- 19 Barbacid M. Ras genes. Annu Rev Biochem 1987; 56: 779–827.
- 20 Bos JL. The ras gene family and human carcinogenesis. Mutat Res 1988; 195: 255–271.
- 21 Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-Ki-ras genes. Cell 1988; 53: 549–554.
- 22 Gu J-R, Hu L-F, Cheng Y-C, Wan D-F. Oncogenes in human primary hepatic cancer. J Cell Physiol 1986; 4 (suppl): 13–20.
- 23 Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terada M. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res 1989; 80: 196–199.
- 24 Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305: 779–784.
- 25 Green AR. Recessive mechanisms of malignancy. Br J Cancer 1988; 58: 115–121.
- 26 Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. Loss of heterozygosity in three embryonal tumors suggest a common pathogenetic mechanism. Nature 1985; 316: 330–334.
- 27 Saxon PJ, Srivatsan ES, Stanbridge EJ. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression on Hela cells. EMBO J 1986; 5: 3461–3466.
- 28 Krontiris TG, DiMartino NA, Colb M, Parkinson DR. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumor DNAs of cancer patients. Nature 1985; 313: 369–374.
- 29 Yokota J, Tsunetsugu Y-Y, Battifora H, Le F-C, Cline MJ. Alteration of myc, myb, and Ha-ras protooncogenes in cancers are frequent and show clinical correlation. Science 1986; 231: 261–265.
- 30 Ishikawa J, Maeda S, Takahashi R, Kamidono S, Sugiyama T. Lack of correlation between rare Ha-ras alleles and urothelial cancer in Japan. Int J Cancer 1987; 40: 474–478.
- 31 Lee JH, Kavanagh JJ, Wharton JT, Wildrick DM, Blick M. Allele loss at the c-Ha-ras 1 locus in human ovarian cancer. Cancer Res 1989; 49: 1220–1222.
- 32 De Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB. The short arm of chromosome 11 is a “hot spot” for hypermethylation in human neoplasia. Proc Natl Acad Sci USA 1988; 85: 5693–5697.
- 33 Wang HP, Rogler CE. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 1988; 48: 72–78.
- 34 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–517.
- 35 Wahr GM, Stern M, Stark GR. Efficient transfer of large DNA fragments from agarose gels to diazobenzyl oxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci USA 1979; 76: 3683–3687.
- 36 Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 1983; 302: 33–37.
- 37 Razin A, Riggs AD. DNA methylation and gene function. Science 1980; 210: 604–610.
- 38 Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries V, Van Boom JH, Van der Eb AJ, Vogelstein B. Prevalence of ras gene mutation in human colorectal cancers. Nature 1987; 327: 293–297.
- 39 Hirai H, Kobayashi Y, Mano H, Hagiwara K, Maru Y, Omine M, Mizoguchi H, et al. A point mutation at 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987; 327: 430–432.
- 40 Fujita J, Kraus MH, Onoue H, Srivastava SK, Ebi Y, Kitamura Y, Rhim JS. Activated H-ras oncogenes in human kidney tumors. Cancer Res 1988; 48: 5251–5255.
- 41 Shafritz DA, Rogler CE. Molecular characterization of viral forms observed in persistent hepatitis infections, chronic liver disease and hepatocellular carcinoma in woodchucks and humans. In: GN Vyas, JL Dienstag, JH Hoofnagle, eds. Viral hepatitis and liver disease. Orlando, Fla: Grune & Stratton, Inc., 1984: 225–243.
- 42 Ogata N, Kojima T, Kamimura T, Ichida F, Hamada C. Mode of integration of hepatitis B virus DNA in chronically infected livers with indications of multiclonal growth of hepatocytes and some hepatoma cells. In: AJ Zuckerman, ed. Viral hepatitis and liver disease. New York: Aran R. Liss, Inc., 1988: 746–751.
- 43 Fu X-X, Su C-Y, Lee Y, Hintz R, Biempica L, Snyder R, Rogler CE. Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol 1988; 62: 3422–3430.
